Zhang, Samuel C.
Atkins, Katelyn M.
Chung, Eric M.
Kamrava, Mitchell
Article History
Received: 2 November 2022
Accepted: 2 November 2022
First Online: 11 November 2022
Declarations
:
: Samuel C. Zhang and Eric M. Chung each declare no potential conflicts of interest.Katelyn M. Atkins has received personal fees from Onclive.Mitchell Kamrava has received personal fees from Springer and Theragenics, and serves on the following: American Brachytherapy Society — Board of Directors, Member at Large, Association for Directors of Radiation Oncology Programs — Board of Directors, Member at Large, Alessa — Data and Safety Monitoring Board, and Gammatile — Data and Safety Monitoring Board.
: This article does not contain any studies with human or animal subjects performed by any of the authors.